Saudi FDA Wants Drug & Device Firms To Report Payments To Doctors, Health Institutions
Executive Summary
The Saudi Food and Drug Authority has finalized the details of a new transparency initiative under which drug and medical device companies will have to disclose their financial relationships with healthcare professionals and institutions.
You may also be interested in...
Sunshine Website Goes Live With Some Context Sought By Industry
CMS releases data on $3.5 billion worth of payments made by drug and device companies to physicians and teaching hospitals in the last five months of 2013; an additional 199,000 payment records were not disclosed.
The new EFPIA code on disclosure of transfers of value: a meaningful path to transparency?
Vincenzo Salvatore, Hae-Won Min Liao and Catherine Starks discuss the new code.
Misinformation Prompted Six Court Cases Against EU COVID-19 Vaccine Approvals In 2021
The EU’s conditional approval of four COVID-19 vaccines and its decision to extend the use of Pfizer/BioNTech’s Comirnaty to a younger age group were challenged in the court last year but the cases were declared inadmissible.